Sirio Pharma (300791) — Financial Flexibility Index
Sirio Pharma (300791) has a Financial Flexibility Index of 0.09x as of June 2023. Free cash flow of CN¥161.25 Million (operating CF CN¥101.61 Million minus capex CN¥59.65 Million) represents 0% of total liabilities (CN¥1.85 Billion). Check Sirio Pharma (300791) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Sirio Pharma Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Sirio Pharma across 9 annual periods. For the full cash flow conversion analysis, see 300791 cash generation efficiency.
Annual Financial Flexibility Index for Sirio Pharma (2016–2024)
Year-by-year free cash flow to debt coverage for Sirio Pharma. Explore 300791 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.34x | CN¥979.10 Million | CN¥566.97 Million | CN¥2.84 Billion | ▲ +8.0% |
| 2023 | 0.32x | CN¥837.79 Million | CN¥386.08 Million | CN¥2.63 Billion | ▼ -36.0% |
| 2022 | 0.50x | CN¥738.55 Million | CN¥444.86 Million | CN¥1.48 Billion | ▼ -26.7% |
| 2021 | 0.68x | CN¥866.06 Million | CN¥341.38 Million | CN¥1.28 Billion | ▼ -41.6% |
| 2020 | 1.16x | CN¥542.72 Million | CN¥319.57 Million | CN¥466.95 Million | ▲ +20.7% |
| 2019 | 0.96x | CN¥398.50 Million | CN¥231.60 Million | CN¥414.01 Million | ▲ +72.9% |
| 2018 | 0.56x | CN¥422.78 Million | CN¥183.46 Million | CN¥759.53 Million | ▲ +88.3% |
| 2017 | 0.30x | CN¥209.18 Million | CN¥49.35 Million | CN¥707.58 Million | ▲ +1250.8% |
| 2016 | -0.03x | CN¥-25.61 Million | CN¥-98.26 Million | CN¥997.00 Million | — |